CNI Q3 Beat Confirms Cost Discipline, But Watch Capex and Regulatory Risk

What happened

Canadian National Railway reported higher third-quarter earnings and revenue, with volume growth, pricing, and productivity improvements offsetting higher costs, and the company reaffirmed its full-year outlook while tracking toward the upper end of adjusted EPS guidance. This positive print aligns with the DeepValue master report's base case, which anticipated mid-single-digit EPS growth driven by cost cuts and normalized capex, but it does not resolve the key uncertainties flagged: potential regulatory mandates for safety systems and the durability of the C$2.8 billion 2026 capex plan. The master report rated CNI a WAIT, noting that at ~$99 (P/E ~19x, EV/EBITDA ~12x) the market prices in flawless execution, leaving limited upside unless the stock pulls back or risks diminish. The Q3 results demonstrate management's ability to defend margins in a flat-volume environment, but they also highlight the reliance on cost control rather than volume growth, which remains subject to tariff and macro headwinds. Therefore, while the earnings beat is encouraging, it does not materially change the risk-reward profile, and investors should continue to monitor capex guidance and regulatory developments closely.

Implication

The reaffirmed full-year outlook and upper-end EPS tracking increase confidence in the base case, but the core risks—capex escalation from safety mandates and the inability to sustain EPS growth if tariffs intensify—remain unresolved. Investors should wait for either a pullback toward the attractive entry around $88 or concrete evidence that 2026 capex stays near C$2.8 billion and operating ratios continue to improve. Any announcement of regulatory rules requiring fail-safe train controls would likely force an upward revision to capex and compress free cash flow, undermining the thesis. Conversely, if the stock pulls back below $90 while capex guidance holds, it would present a more attractive entry point. Until then, the valuation at near $99 offers insufficient margin of safety for a sizeable position.

Thesis delta

The Q3 earnings report confirms strong operational execution and reaffirms guidance, shifting probability slightly toward the base case (implied value ~$105) from the bear case, but the fundamental WAIT rating remains unchanged. No material information on 2026 capex, regulatory mandates, or tariff resolution was provided, so the key risks identified in the master report are still in play. The thesis delta is therefore minimal: confidence in the cost-out algorithm increases modestly, but the absence of new capex guidance or regulatory clarity prevents a more constructive stance.